D. Comings

发表

The proenkephalin gene (PENK) and opioid dependence.

G. Saucier, R. Legro, D. Comings, 1999, Neuroreport.

The DRD4 gene and the spiritual transcendence scale of the character temperament index.

G. Saucier, D. Comings, N. Gonzales, 2000, Psychiatric genetics.

Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder

G Saucier, D. Comings, G. Saucier, 2000, Clinical genetics.

Association between the adrenergic alpha 2A receptor gene (ADRA2A) and measures of irritability, hostility, impulsivity and memory in normal subjects.

M. McGue, G. Saucier, D. Comings, 2000, Psychiatric genetics.

Two single nucleotide polymorphisms in the promoter region of the human phenylethanolamine N-methyltransferase PNMT gene.

D. Comings, D. Comings, S. Wu, 1999, Psychiatric genetics.

Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat.

D. Comings, G. Dietz, D. Muhleman, 1995, Genomics.

Human tryptophan oxygenase localized to 4q31: possible implications for alcoholism and other behavioral disorders.

T. Donlon, D. Comings, G. Dietz, 1991, Genomics.

Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.

E. Ruoslahti, D. Comings, M. Seppala, 1979, British medical journal.

The additive effect of neurotransmitter genes in pathological gambling

D. Comings, R. Rosenthal, D. Comings, 2001, Clinical genetics.

A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory

G. Saucier, D. Comings, H. Blake, 2000, Clinical genetics.

Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence

G. Saucier, D. Comings, P. Johnson, 1999, Molecular Psychiatry.

Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease.

W. Tourtellotte, D. Comings, J. Macmurray, 2001, American journal of medical genetics.

G5644A polymorphism in the interferon‐gamma (INFG) gene

D. Comings, S. Wu, D. Muhleman, 1998, Psychiatric genetics.

Association of the N‐acetyltransferase 1 gene (NAT1) with mild and severe substance abuse

D. Comings, J. Macmurray, D. Muhleman, 2000, Neuroreport.

Potential role of the estrogen receptor gene (ESR1) in anxiety

D. Comings, P. Johnson, J. Macmurray, 1999, Molecular Psychiatry.

Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples.

W. Iacono, M. McGue, D. Comings, 2001, Molecular genetics and metabolism.

A common C-1018G polymorphism in the human 5-HT1A receptor gene.

D. Comings, S. Wu, S Wu, 1999, Psychiatric genetics.

Role of the cholinergic muscarinic 2 receptor (CHRM2) gene in cognition

M. McGue, D. Comings, J. MacMurray, 2003, Molecular Psychiatry.

Antigenic differences in nuclear proteins of normal liver and hepatoma

E. Engvall, E. Ruoslahti, D. Comings, 1977, The Journal of experimental medicine.

The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome

D. Comings, K. Blum, E. Braverman, 1996, Journal of the Royal Society of Medicine.

Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB)

D. Comings, K. Blum, A. Pontius, 1997, Molecular Psychiatry.

Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12-->p11 by fluorescent in situ hybridization.

V. Najfeld, D. Comings, D. Muhleman, 1993, Cytogenetics and cell genetics.

Association of the neutral endopeptidase (MME) gene with anxiety.

G. Saucier, D. Comings, H. Blake, 2000, Psychiatric genetics.

Association of the enkephalinase gene with low amplitude P300 waves.

D. Comings, G. Dietz, J. Johnson, 1999, Neuroreport.